Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.
Harding C, Chadwick T, Homer T, Lecouturier J, Mossop H, Carnell S, King W, Abouhajar A, Vale L, Watson G, Forbes R, Currer S, Pickard R, Eardley I, Pearce I, Thiruchelvam N, Guerrero K, Walton K, Hussain Z, Lazarowicz H, Ali A.
Harding C, et al.
Health Technol Assess. 2022 May;26(23):1-172. doi: 10.3310/QOIZ6538.
Health Technol Assess. 2022.
PMID: 35535708
Free article.
Clinical Trial.
Emerging antimicrobial resistance is a global health concern, prompting research interest in non-antibiotic agents such as methenamine hippurate, but comparative data on their efficacy and safety are lacking. OBJECTIVE: To assess the clinical effectiveness and cost-effecti …
Emerging antimicrobial resistance is a global health concern, prompting research interest in non-antibiotic agents such as methenamine …